1.2720
-0.0380
(-2.90%)
At close: January 10 at 8:07:38 AM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in EUR | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | -- | 2 | 2 |
| Avg. Estimate | 1.9M | -- | 3.37M | 8.82M |
| Low Estimate | 1.9M | -- | 2.8M | 8.75M |
| High Estimate | 1.9M | -- | 3.93M | 8.9M |
| Year Ago Sales | 401k | -- | 2.57M | 3.37M |
| Sales Growth (year/est) | 373.82% | -- | 31.14% | 162.26% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 4YL.F | -- | -- | -- | -- |
| S&P 500 | 8.66% | 11.51% | 14.05% | 13.39% |
Related Tickers
SCP.F Scancell Holdings plc
0.0960
+16.36%
SCNLF Scancell Holdings plc
0.1800
0.00%
6XP.SG Xspray Pharma AB (publ)
2.9600
-6.03%
0M4.F Mersana Therapeutics, Inc.
0.8396
-29.53%
XSPRAY.ST Xspray Pharma AB (publ)
29.25
-15.34%
SYNACT.ST SynAct Pharma AB
11.09
-5.29%
SCLP.L Scancell Holdings plc
10.10
+3.59%
HNSA.ST Hansa Biopharma AB (publ)
34.78
-0.69%
5CV.DE CureVac N.V.
4.2660
+9.61%
FLUO.ST FluoGuide A/S
46.70
-2.91%